Paxil and Dermatitis exfoliative aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative aggravated is reported as a side effect among people who take Paxil (paroxetine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Accutane, and have Chronic phase chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Dermatitis exfoliative aggravated when taking Paxil. It is created by eHealthMe based on reports of 88,676 people who have side effects when taking Paxil from the FDA, and is updated regularly.

What is Paxil?

Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 92,546 Paxil users. Check the latest studies of Paxil.

What is Dermatitis exfoliative aggravated?

Dermatitis exfoliative aggravated (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 625 drugs and 336 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative aggravated.

On Jul, 16, 2026

88,676 people reported to have side effects when taking Paxil.
Among them, 35 people (0.04%) have Dermatitis exfoliative aggravated.

Could Paxil cause Dermatitis exfoliative aggravated?

Among these 35 people:

How long have people been on Paxil when they have Dermatitis exfoliative aggravated? *

What is the gender of people who have Dermatitis exfoliative aggravated when taking Paxil? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Dermatitis exfoliative aggravated when taking Paxil? *

What are other drugs people take besides Paxil? *

What are other side effects people have besides Dermatitis exfoliative aggravated? *

Fever: 12 people, 34.29%
Rashes (redness): 8 people, 22.86%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 20.00%
Nausea (feeling of having an urge to vomit): 6 people, 17.14%
Itching: 6 people, 17.14%
Face Oedema (swelling of face): 6 people, 17.14%
Rash Erythematous (redness of the skin): 5 people, 14.29%
Joint Pain: 4 people, 11.43%
Dry Skin: 4 people, 11.43%
Lip Dry: 4 people, 11.43%

What are the existing conditions these people have? *

Chronic Phase Chronic Myeloid Leukaemia (blood cancer): 2 people, 5.71%
Pustular Psoriasis (raised bumps on the skin that are filled with pus): 1 person, 2.86%
Prostate Cancer: 1 person, 2.86%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 2.86%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 2.86%
Migraine (headache): 1 person, 2.86%
Ill-Defined Disorder: 1 person, 2.86%
Gout (uric acid crystals building up in the body): 1 person, 2.86%
Depressive Symptom: 1 person, 2.86%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Paxil and have Dermatitis exfoliative aggravated?

- Check whether Dermatitis exfoliative aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paxil:

Paxil (92,546 reports)

Browse all side effects of Paxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (625 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (336 conditions)

Related publications that referenced our studies

Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride (the active ingredients of Paxil) and Paxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.